Maternal Plasma and Cord Blood Concentration Profiles of Duloxetine During the Peripartum Period and Their Associations With the Modified Finnegan Score.

Taguchi, Reina; Naito, Takafumi; Suzuki, Koji; Kurosawa, Yuko; Itoh, Hiroaki; Kawakami, Junichi

Taguchi, Reina; Naito, Takafumi; Suzuki, Koji; Kurosawa, Yuko; Itoh, Hiroaki; Kawakami, Junichi.

Afiliação

Taguchi R; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Naito T; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Suzuki K; Department of Pharmacy, Shinshu University Hospital, Matsumoto, Nagano, Japan, and.
Kurosawa Y; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Itoh H; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kawakami J; Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Ther Drug Monit ; 44(2): 351-352, 2022 04 01.

Article em En | MEDLINE | ID: mdl-34812767

Assuntos

Sangue Fetal; Período Periparto; Cloridrato de Duloxetina; Humanos; Plasma; Fatores de Risco

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sangue Fetal / Período Periparto Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ther Drug Monit Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google